deucravacitinib

CHEBI:CHEBI_749989

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Deucravacitinib
rxcui
2612098
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
ORAL
dosage_form
POWDER
active_ingredient_strength
1 kg/kg
marketing_start_date
20220910
labeler_name
SK biotek Ireland Limited
manufacturer_name
E.R. Squibb & Sons, L.L.C.
package_marketing_start_date
13-SEP-22
brand_name
SOTYKTU
brand_name_base
SOTYKTU
product_ndc
50193-4323
application_number
NDA214958
spl_id
0aea247f-c889-33e6-e063-6394a90a709f
spl_set_id
ff4d7258-5068-4cdf-9692-8cae04c3198e
active_ingredient_name
DEUCRAVACITINIB
package_ndc
50193-4323-2
package_description
15 kg in 1 DRUM (50193-4323-2)
unii
N0A21N6RAU
nui
N0000194044
pharm_class_epc
Tyrosine Kinase 2 Inhibitor [EPC]
pharm_class_moa
Tyrosine Kinase 2 Inhibitors [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class